companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

GSK GIFTS

WHITE PLAINS-USA

Company Name:
Corporate Name:
GSK GIFTS
Company Title: tikirepublic.com 
Company Description:  
Keywords to Search:  
Company Address: 719 MALLARD DR,WHITE PLAINS,GA,USA 
ZIP Code:
Postal Code:
30678 
Telephone Number: 7708688619 (+1-770-868-8619) 
Fax Number:  
Website:
tikirepublic. com 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
594515 
USA SIC Description:
Baskets 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
WINTERS INTERNATIONAL
HUBBARD SOFTWARE CORPORATION
LONG & FOSTER REAL ESTATE INC
Next company profile:
SAFARI BAR AND GRILL;
LEWIS MACHINING & ENGINEERING; INC
LAMP POST FINIALS










Company News:
  • Home | GSK US
    Meet Shreya: From hot pink goggles to scientist Shreya shares her journey from when she was a little girl in Science in Summer to having a career at GSK today
  • GSK begins shipping influenza vaccine doses for the 2025-26 flu season . . .
    GSK has begun shipping trivalent flu vaccine doses to US healthcare providers and pharmacies for the 2025–26 flu season
  • Products - GSK US
    Unfortunately, we cannot provide comprehensive information about our products here, in compliance with regulations If you are a healthcare professional, you can access more product information on our GSKPro website In the US, if you are a patient and have questions about our medicines, please contact the GSK Response Center
  • Inclusion | GSK US
    To be a successful business and deliver positive health impact at scale, we must meet patients’ needs with research that includes those impacted by the disease under study, attract and retain the best talent regardless of background, and support all GSK people to thrive
  • FDA approves Benlysta (belimumab) Autoinjector for children with active . . .
    With this approval, GSK is expanding choices for belimumab treatment, offering pediatric lupus nephritis patients and caregivers a first-of-its-kind subcutaneous option that can be administered at home
  • Vaccines | GSK US
    The vaccines in our portfolio have been helping to protect people from serious disease for well over 100 years, with our Marietta, PA site dedicated to smallpox vaccine production since 1882 Today, our vaccines continue to make an impact for society by tackling some of the world’s most devastating diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough and
  • Careers | GSK US
    At GSK, we unite science, technology and talent to get ahead of disease together We aim to positively impact the health of 2 5 billion people by the end of the decade, as a successful, growing company where people can thrive
  • GSK invests $120 million in next-generation US biopharmaceutical . . .
    GSK today announced a $120 million investment to expand its manufacturing facility in Upper Merion, Pennsylvania that will support the delivery of the company’s pipeline, bringing new medicines for cancer and other specialty diseases to patients faster
  • Therapeutic areas - GSK US
    Explore innovations in medicines and healthcare from inside and outside our labs Discover more about what we do, the people behind GSK and how we operate responsibly for all our stakeholders by prioritizing Innovation, Performance and Trust
  • GSK announces cap of $35 per month on U. S. patient out-of-pocket costs . . .
    GSK will share specific details closer to implementation Today’s announcement builds on GSK’s strong track record of increasing access and improving the affordability of its medicines, including an ongoing commitment to responsible pricing




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer